Entropy Neurodynamics Limited (ASX:ENP)
Australia · Delayed Price · Currency is AUD 0.0320
0.00 (0.00%)
Oct 22, 2026, 4:10 PM AEDT
Entropy Neurodynamics Market Cap
Entropy Neurodynamics has a market cap or net worth of 52.28 million as of October 22, 2026. It is the 32,555th most valuable company in the world and the 763rd biggest in Australia. Its market cap has decreased by 4.46% in one year.
Market Cap
52.28M
Enterprise Value
46.70M
Revenue
1.91M
Global Rank
Country Rank
#763 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since May 29, 2024, Entropy Neurodynamics's market cap has increased from 38.06M to 52.28M, an increase of 37.34%. That is a compound annual growth rate of 14.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 52.28M | 1.57% |
| Dec 31, 2025 | 51.47M | 6.11% |
| Dec 31, 2024 | 48.50M | 27.43% |
| May 29, 2024 | 38.06M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Island Pharmaceuticals | 97.71M |
| LTR Pharma | 85.67M |
| Prescient Therapeutics | 66.34M |
| Neurizon Therapeutics | 62.01M |
| Alterity Therapeutics | 61.86M |
| Arovella Therapeutics | 60.44M |
| Avecho Biotechnology | 54.09M |
| Amplia Therapeutics | 41.06M |